<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02508922</url>
  </required_header>
  <id_info>
    <org_study_id>NCHVitDASD</org_study_id>
    <nct_id>NCT02508922</nct_id>
  </id_info>
  <brief_title>Trial of Vitamin D3 Supplementation in Paediatric Autism</brief_title>
  <official_title>Vitamin D3 for Autism Spectrum Disorder: a Randomized, Double-blind, Placebo-controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Dublin, Trinity College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The National Children's Hospital, Tallaght</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Dublin, Trinity College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To build on a recent case study and open label trial, the investigators want to find out if
      vitamin D supplementation can influence behavioural and core symptoms of autism.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will assess behavioural and core symptoms of autism before and after 20
      weeks of vitamin D supplementation in a double-blind, placebo-controlled trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in stereotypic behaviour from the aberrant behaviour checklist</measure>
    <time_frame>Day 1 and day 140</time_frame>
    <description>A subscale derived from the validated aberrant behaviour checklist</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in serum 25-hydroxyvitamin D levels</measure>
    <time_frame>Day 1 and day 140</time_frame>
    <description>Total vitamin D levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in serum calcium levels, corrected for albumin</measure>
    <time_frame>Day 1 and day 140</time_frame>
    <description>Total serum calcium levels indicating calcium balance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in aberrant behaviour checklist</measure>
    <time_frame>Day 1 and day 140</time_frame>
    <description>A validated scale for use in autism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in cytokines</measure>
    <time_frame>Day 1 and day 140</time_frame>
    <description>Serum will be analysed for specific cytokines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in autoimmune markers</measure>
    <time_frame>Day 1 and day 140</time_frame>
    <description>Serum will be analysed for specific autoimmune markers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in behaviour Assessment System for Children - Second Edition</measure>
    <time_frame>Day 1 and day 140</time_frame>
    <description>A validated scale for use in autism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in repetitive behavior Scale - Revised</measure>
    <time_frame>Day 1 and day 140</time_frame>
    <description>A validated scale for use in autism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Social Responsiveness Scale</measure>
    <time_frame>Day 1 and day 140</time_frame>
    <description>A validated scale for use in autism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Developmental Disabilities—Children's Global Assessment Scale</measure>
    <time_frame>Day 1 and day 140</time_frame>
    <description>A clinical global impression of autism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Vitamin D and Sun Questionnaire</measure>
    <time_frame>Day 1 and day 140</time_frame>
    <description>A scale assessing behaviour related to vitamin D</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Autism</condition>
  <arm_group>
    <arm_group_label>Vitamin D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2000iu vitamin D will be taken daily for 20 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo drops will be taken daily for 20 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>2,000iu vitamin D drops will be taken daily for 20 weeks</description>
    <arm_group_label>Vitamin D3</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching placebo drops will be taken daily for 20 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Positive autism diagnostic observation schedule

          -  Stable medication regimen

          -  Tolerate phlebotomy

        Exclusion Criteria:

          -  Unstable or very severe autism

          -  Epilepsy

          -  Renal/liver/gastrointestinal disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Linn Dara and BeechPark</name>
      <address>
        <city>Dublin</city>
        <zip>D10</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Children's Hopsital</name>
      <address>
        <city>Dublin</city>
        <zip>D24</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trinity College Dublin</name>
      <address>
        <city>Dublin</city>
        <zip>D2</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <reference>
    <citation>Cannell JJ. Autism and vitamin D. Med Hypotheses. 2008;70(4):750-9. Epub 2007 Oct 24.</citation>
    <PMID>17920208</PMID>
  </reference>
  <reference>
    <citation>Eyles DW. Vitamin D and autism: does skin colour modify risk? Acta Paediatr. 2010 May;99(5):645-647. doi: 10.1111/j.1651-2227.2010.01797.x. Epub 2010 Mar 8.</citation>
    <PMID>20219042</PMID>
  </reference>
  <reference>
    <citation>Becker KG. Autism, immune dysfunction and Vitamin D. Acta Psychiatr Scand. 2011 Jul;124(1):74; author reply 74-5. doi: 10.1111/j.1600-0447.2011.01688.x. Epub 2011 Mar 13.</citation>
    <PMID>21395563</PMID>
  </reference>
  <reference>
    <citation>Kočovská E, Fernell E, Billstedt E, Minnis H, Gillberg C. Vitamin D and autism: clinical review. Res Dev Disabil. 2012 Sep-Oct;33(5):1541-50. doi: 10.1016/j.ridd.2012.02.015. Epub 2012 Apr 21.</citation>
    <PMID>22522213</PMID>
  </reference>
  <reference>
    <citation>Mostafa GA, Al-Ayadhi LY. Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity. J Neuroinflammation. 2012 Aug 17;9:201.</citation>
    <PMID>22898564</PMID>
  </reference>
  <reference>
    <citation>Cannell JJ. Autism, will vitamin D treat core symptoms? Med Hypotheses. 2013 Aug;81(2):195-8. doi: 10.1016/j.mehy.2013.05.004. Epub 2013 May 29.</citation>
    <PMID>23725905</PMID>
  </reference>
  <reference>
    <citation>Cannell JJ, Grant WB. What is the role of vitamin D in autism? Dermatoendocrinol. 2013 Jan 1;5(1):199-204. doi: 10.4161/derm.24356.</citation>
    <PMID>24494055</PMID>
  </reference>
  <reference>
    <citation>Patrick RP, Ames BN. Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J. 2014 Jun;28(6):2398-413. doi: 10.1096/fj.13-246546. Epub 2014 Feb 20. Review.</citation>
    <PMID>24558199</PMID>
  </reference>
  <reference>
    <citation>Jia F, Wang B, Shan L, Xu Z, Staal WG, Du L. Core symptoms of autism improved after vitamin D supplementation. Pediatrics. 2015 Jan;135(1):e196-8. doi: 10.1542/peds.2014-2121. Epub 2014 Dec 15.</citation>
    <PMID>25511123</PMID>
  </reference>
  <reference>
    <citation>Saad K, Abdel-Rahman AA, Elserogy YM, Al-Atram AA, Cannell JJ, Bjørklund G, Abdel-Reheim MK, Othman HA, El-Houfey AA, Abd El-Aziz NH, Abd El-Baseer KA, Ahmed AE, Ali AM. Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr Neurosci. 2016 Oct;19(8):346-351. Epub 2015 Apr 15.</citation>
    <PMID>25876214</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2015</study_first_submitted>
  <study_first_submitted_qc>July 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2015</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Dublin, Trinity College</investigator_affiliation>
    <investigator_full_name>Conor Kerley</investigator_full_name>
    <investigator_title>Dietitian and Nutrition Scientist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

